Spiperone is a antipsychotic that has been used to treat schizophrenia. Additionally, spiperone was identified by compound screening to be an activator of Ca2+ activated Cl– channels (CaCCs), thus a potential target for therapy of cystic fibrosis. References: Skurikhin EG, Ermakova NN, Reztsova AM, Pershina OV, Khmelevskaya ES, Krupin VA, Stepanova IE, Reztsova VM, Reihard DV, Artamonov AV, Bekarev AA, Madonov PG, Kinsht DN, Goldberg VE, Dygai AM. Anti-inflammatory and antifibrotic effects of a combination of spiperone and immobilized hyaluronidase on partially reversible and irreversible (covalent) toxic pneumofibrosis. Bull Exp Biol Med. 2013 Nov;156(1):53-8. PubMed PMID: 24319728.

纯度：≥98%

CAS：749-02-0